The initiation of Phase 2 trials for PF-07081532 would trigger a new milestone payment, from which Sosei Heptares would receive $10 million from Pfizer
PubMed Lall, S., Tung, L.Y., Ohlsson, C., Jansson, J.O., & Dickson, S.L
Nonetheless, these clinical trials were underpowered to detect rare events such as suicidal ideation and self-injurious behavior, and they systematically excluded patients with psychiatric comorbidities commonly seen in clinical settings
Extended Storage: Reconstituted peptide maintains potency for approximately 2 to 4 weeks with proper handling
The severity of injuries now forming the basis of litigation demonstrates why plaintiffs allege manufacturers failed to provide adequate warnings about risks that extend well beyond temporary side effects